117 related articles for article (PubMed ID: 12918099)
21. Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells.
Li T; Xu XH; Tang ZH; Wang YF; Leung CH; Ma DL; Chen XP; Wang YT; Chen Y; Lu JJ
Acta Pharmacol Sin; 2015 Dec; 36(12):1503-13. PubMed ID: 26592509
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor I receptor β expression in hepatocellular carcinoma.
Liu X; Jiang W; Aucejo F; Kim R; Miller C; Byrne M; Lopez R; Yerian L
Hum Pathol; 2011 Jun; 42(6):882-91. PubMed ID: 21292299
[TBL] [Abstract][Full Text] [Related]
23. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
Peavy DE; Abram JD; Frank BH; Duckworth WC
Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
[TBL] [Abstract][Full Text] [Related]
24. A human hepatoma cell line modulates its insulin receptors under different culture conditions.
Festa A; Bagnarelli P; Testa I; Clementi M
Boll Soc Ital Biol Sper; 1985 Oct; 61(10):1409-16. PubMed ID: 3006728
[No Abstract] [Full Text] [Related]
25. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
[TBL] [Abstract][Full Text] [Related]
26. Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.
Morzyglod L; Caüzac M; Popineau L; Denechaud PD; Fajas L; Ragazzon B; Fauveau V; Planchais J; Vasseur-Cognet M; Fartoux L; Scatton O; Rosmorduc O; Guilmeau S; Postic C; Desdouets C; Desbois-Mouthon C; Burnol AF
Hepatology; 2017 Apr; 65(4):1352-1368. PubMed ID: 27981611
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product.
Kim SO; Park JG; Lee YI
Cancer Res; 1996 Aug; 56(16):3831-6. PubMed ID: 8706031
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
29. [Hepatocarcinoma cell lines in vitro: binding of insulin].
Testa I; Clementi M; Festa A; Bagnarelli P
Boll Soc Ital Biol Sper; 1987 Jul; 63(7):567-73. PubMed ID: 2822064
[No Abstract] [Full Text] [Related]
30. Human insulin receptor and insulin signaling proteins in hepatic disease.
Spector SA; Olson ET; Gumbs AA; Friess H; Büchler MW; Seymour NE
J Surg Res; 1999 May; 83(1):32-5. PubMed ID: 10210639
[TBL] [Abstract][Full Text] [Related]
31. Metformin modulates insulin post-receptor signaling transduction in chronically insulin-treated Hep G2 cells.
Yuan L; Ziegler R; Hamann A
Acta Pharmacol Sin; 2003 Jan; 24(1):55-60. PubMed ID: 12511230
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.
Daghighian F; Humm JL; Macapinlac HA; Zhang J; Izzo J; Finn R; Kemeny N; Larson SM
J Nucl Med; 1996 Apr; 37(4 Suppl):29S-32S. PubMed ID: 8676201
[TBL] [Abstract][Full Text] [Related]
33. [Study of insulin receptors on liver and hepatoma cell plasma membranes].
Shelepov VP; Davydova SIa; Shapot VS
Biokhimiia; 1978 Mar; 43(3):539-44. PubMed ID: 207360
[TBL] [Abstract][Full Text] [Related]
34. Docetaxel shows radiosensitization in human hepatocellular carcinoma cells.
Geng CX; Zeng ZC; Wang JY; Xuan SY; Lin CM
World J Gastroenterol; 2005 May; 11(19):2990-3. PubMed ID: 15902743
[TBL] [Abstract][Full Text] [Related]
35. Latest developments in targeted therapy for hepatocellular carcinoma.
Montella L; Addeo R; Caraglia M; Del Prete S
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1635-46. PubMed ID: 20942634
[TBL] [Abstract][Full Text] [Related]
36. [AUTORADIOGRAPHIC STUDIES ON THE INCORPORATION OF 5-IODO-2-DESOXYURIDINE (IUDR) INTO THE DNA OF CELLS OF YOSHIDA HEPATOMA AH 130].
OEHLERT W; MAGNUSSON B
Z Krebsforsch; 1965 Feb; 66():455-9. PubMed ID: 14263005
[No Abstract] [Full Text] [Related]
37. Insulin and insulin-like growth factor I regulate the same biological functions in HEP-G2 cells via their own specific receptors.
Verspohl EJ; Maddux BA; Goldfine ID
J Clin Endocrinol Metab; 1988 Jul; 67(1):169-74. PubMed ID: 2837499
[TBL] [Abstract][Full Text] [Related]
38. Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors.
Loukovaara M; Carson M; Adlercreutz H
J Clin Endocrinol Metab; 1995 Jan; 80(1):160-4. PubMed ID: 7829605
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
[TBL] [Abstract][Full Text] [Related]
40. High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells.
Lou B; Liao XL; Wu MP; Cheng PF; Yin CY; Fei Z
World J Gastroenterol; 2005 Feb; 11(7):954-9. PubMed ID: 15742395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
